Viatris Inc

VTRS - CIK 0001792044

Market cap$18.36 B

Rank#647

SEC filings519

Viatris Inc trades as VTRS and has a market capitalization of $18.36 B, making it the #647 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $14.25B, down 3.0% from the prior year and net income of $0.00. This page tracks Viatris Inc through 519 SEC filings, with financial statements and metrics updated as new reports are filed.

Key metrics

Revenue (latest FY)$14.25BFY 2025

Net income (latest FY)$0.00FY 2019

Operating cash flow (latest FY)$2.32BFY 2025

Total assets (latest FY)$37.19BFY 2025

Gross margin35.2%latest FY

Financial performance

Over the last 7 fiscal years Viatris Inc's revenue grew from $11.27B to $14.25B, a compound annual growth rate of 3.4%.

VTRS annual revenueView details

Key statistics

Market cap: $18.36 B
Share price (derived)market cap / shares outstanding: $15.77
EPS (diluted)FY 2025: $-3.00
Shares outstandingas of 2026-05-04: 1.16B
Long-term debtas of 2026-03-31: $12.41B
Cash & equivalentsas of 2026-03-31: $1.80B
Stock buybacksFY 2025: $500.50M
Current ratioas of 2026-03-31: 1.60

Latest filings

Filing	Type	Filed
Major company event	8-K	2026-05-15
Quarterly report	10-Q	2026-05-07
Major company event	8-K	2026-05-07
SCHEDULE 13G/A	-	2026-05-05
Major company event	8-K	2026-05-04
SCHEDULE 13G	-	2026-04-30
Insider trade	4	2026-04-16
Annual report to shareholders	ARS	2026-04-02

Browse the full filing history (519 filings)

Recent press releases

Research and Reports2026-05-18
U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain | Viatris
Research and Reports2026-05-07
Viatris to Present at the Bank of America Securities 2026 Healthcare Conference | Viatris
Viatris Reports First-Quarter 2026 Financial Results2026-05-07
Viatris Reports First-Quarter 2026 Financial Results | Viatris
Viatris Announces Quarterly Dividend2026-05-05
The page you are about to visit contains information about Viatris that is specific to Spain . Regulatory requirements, data protection requirements and practices or medical practices may differ between countries, and therefore the information provided on this page may not be suitable for use in all countries.
Viatris Announces Chief Financial Officer Transition2026-05-04
Viatris Announces Chief Financial Officer Transition | Viatris

Similar companies

The largest companies sharing Viatris Inc's SEC industry classification (pharmaceutical preparations).

LLYEli Lilly and Company$1.072 T VTRS vs LLY

JNJJohnson & Johnson$573.98 B VTRS vs JNJ

ABBVAbbVie Inc.$399.47 B VTRS vs ABBV

MRKMerck & Co., Inc.$293.16 B VTRS vs MRK

AZNAstraZeneca PLC$286.27 B VTRS vs AZN

Frequently asked questions

What is Viatris Inc's market cap?

Viatris Inc (VTRS) has a market capitalization of $18.36 B as of 2026-06-10, ranking #647 among US-listed companies.

How much revenue does Viatris Inc make?

Viatris Inc reported revenue of $14.25B for fiscal year 2025, a decrease of 3.0% year over year.

Is Viatris Inc profitable?

Yes. Viatris Inc reported net income of $0.00 in its latest fiscal year.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.